Skip to search formSkip to main contentSkip to account menu

MORAb-003

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

farletuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
FOLATE RECEPTOR-ALPHA AND THE EFFECT OF CHEMOTHERAPY ON EXPRESSION RATES IN OVARIAN CANCER
BACKGROUND Folate receptor alpha (FR-α) has been identifi ed as a potential target in ovarian cancer for diagnostic and… 
2012
2012
Abstract 4411: Farletuzumab (mAb003), a neutralizing monoclonal antibody to folate receptor alpha, enhances paclitaxel efficacy in an ovarian cancer model
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Farletuzumab, MORAb-003 is a humanized monoclonal… 
2010
2010
Modulators of Response to Tumor Necrosis-Factor-related Apoptosis Inducing Ligand (TRAIL) Therapy in Ovarian Cancer PRINCIPAL INVESTIGATOR:
2007
2007
A phase I study of MORAb-003, a fully humanized monoclonal antibody against folate receptor alpha, in advanced epithelial ovarian cancer
5517 Background: MORAb-003 (M3) is a humanized monoclonal antibody against the folate receptor alpha (FRA) which is over…